Shimla Online

Arbovirus Infection Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032),| Key Companies – Sanofi, Takeda, Novartis, GlaxoSmithKline

 Breaking News
  • No posts were found

Arbovirus Infection Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032),| Key Companies – Sanofi, Takeda, Novartis, GlaxoSmithKline

April 20
00:56 2023
Arbovirus Infection Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032),| Key Companies - Sanofi, Takeda, Novartis, GlaxoSmithKline
DelveInsight Business Research LLP
DelveInsight’s “Arbovirus Infection Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Arbovirus Infection, historical and forecasted epidemiology as well as the Arbovirus Infection market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Arbovirus Infection Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Arbovirus Infection, historical and forecasted epidemiology as well as the Arbovirus Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

 Arbovirus Infection Overview

Arbovirus is an informal name for any virus transmitted by arthropod vectors. The term arbovirus is a portmanteau word (arthropod-borne virus). Tibovirus (tick-borne virus) is sometimes used to more precisely describe viruses transmitted by ticks, a superorder within the arthropods. Arboviruses can affect both animals (including humans) and plants. In humans, symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last three or four days. The most common clinical features of the disease are fever, headache, and malaise, but encephalitis and viral hemorrhagic fever may also occur.

 

Arbovirus Infection Epidemiology Insights

  • Arbovirus activity peaked consistently during March−May rainy seasons. Overall, arbovirus seroprevalence was 9.5%. Of 137 IgM positives, 52.6% were confirmed by PRNT, of which 73.6% of cases were observed in central Uganda, with the Yellow Fever Virus having the highest prevalence (27.8%). 

  • The 5−14 age group was four times more likely to be infected with an arbovirus p=0.003, 4.1 (95% CI 1.3−12.3). Significant arboviral activity was observed among outdoor workers(p=0.05). 

  • Spatiotemporal analysis indicated arboviral activity in 23 of the 85 districts analyzed.

Click here to learn more about the Arbovirus Infection Market Landscape

The Report Covers the Arbovirus Infection Epidemiology Segmented by:

  • Total Arbovirus Infection incident cases 

  • Total Arbovirus Infection prevalent cases 

  • Total Arbovirus Infection treatment cases 

  • Total Arbovirus Infection diagnostic cases 

Arbovirus Infection Market Outlook

The Arbovirus Infection market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Arbovirus Infection market trends by analyzing the impact of current Arbovirus Infection therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Arbovirus Infection market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion, and exclusion criteria, mechanism of action, compliance rate, growing need for the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Arbovirus Infection market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Arbovirus Infection market in 7MM is expected to change significantly in 2019-2032.

Key Companies Working in the Arbovirus Infection Market

  • Sanofi 

  • Takeda 

  • Novartis 

  • GlaxoSmithKline

  • Themis BioSciences 

  • Emergent BioSolutions 

  • Merck  

And many others 

 Arbovirus Infection Therapies Covered and Analyzed in the Report:

  • VLA1601

  • GLS-5700

  • JNJ-64281802

  •  AT-752

  • JNJ-64281802

  • TAK-003

  • YF-17D

And many others 

Learn more about the Key Companies and Emerging Therapies in the Arbovirus Infection  Market.

 Table of Contents 

  1. Key Insights 

  2. Arbovirus Infection  Introduction 

  3. Executive Summary of Arbovirus Infection    

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Arbovirus Infection   Emerging Therapies

  7. Arbovirus Infection   Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Arbovirus Infection Market Outlook.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services